Rafferty Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$23.2M Sell
193,053
-76,567
-28% -$8.84M 0.09% 115
2025
Q4
$28.4M Sell
269,620
-10,228
-4% -$960K 0.1% 113
2025
Q3
$23.5M Buy
279,848
+11,466
+4% +$944K 0.08% 137
2025
Q2
$21.2M Buy
268,382
+30,670
+13% +$2.44M 0.07% 143
2025
Q1
$21.3M Sell
237,712
-52,722
-18% -$4.92M 0.09% 131
2024
Q4
$28.9M Buy
290,434
+29,554
+11% +$3.05M 0.1% 121
2024
Q3
$29.6M Sell
260,880
-17,704
-6% -$2.1M 0.1% 113
2024
Q2
$34.5M Buy
278,584
+12,966
+5% +$1.67M 0.13% 92
2024
Q1
$35M Buy
265,618
+3,715
+1% +$458K 0.13% 87
2023
Q4
$28.6M Sell
261,903
-6,258
-2% -$650K 0.12% 105
2023
Q3
$27.6M Buy
268,161
+19,769
+8% +$2.13M 0.16% 82
2023
Q2
$28.7M Buy
248,392
+19,079
+8% +$2.17M 0.16% 81
2023
Q1
$24.4M Buy
229,313
+8,481
+4% +$916K 0.17% 86
2022
Q4
$24.5M Buy
220,832
+82,454
+60% +$8.43M 0.21% 81
2022
Q3
$11.9M Buy
138,378
+74,303
+116% +$6.63M 0.13% 126
2022
Q2
$5.84M Sell
64,075
-18,716
-23% -$1.66M 0.05% 259
2022
Q1
$6.79M Sell
82,791
-14,037
-14% -$1.11M 0.04% 279
2021
Q4
$7.42M Buy
96,828
+5,685
+6% +$453K 0.04% 251
2021
Q3
$6.85M Buy
91,143
+32,475
+55% +$2.47M 0.05% 238
2021
Q2
$4.56M Sell
58,668
-376
-0.6% -$28K 0.03% 345
2021
Q1
$4.34M Buy
59,044
+3,862
+7% +$285K 0.03% 314
2020
Q4
$4.31M Sell
55,182
-2,137
-4% -$163K 0.04% 254
2020
Q3
$4.54M Sell
57,319
-12,037
-17% -$943K 0.05% 195
2020
Q2
$5.12M Buy
69,356
+42,166
+155% +$3.17M 0.07% 173
2020
Q1
$2M Sell
27,190
-67,786
-71% -$5.33M 0.08% 147
2019
Q4
$8.24M Buy
94,976
+61,763
+186% +$5.07M 0.13% 91
2019
Q3
$2.67M Sell
33,213
-2,363
-7% -$189K 0.04% 254
2019
Q2
$2.85M Buy
35,576
+28,976
+439% +$2.22M 0.05% 264
2019
Q1
$524K Buy
+6,600
New +$494K 0.01% 665
2018
Q4
Sell
-3,095
Closed -$209K 684
2018
Q3
$209K Buy
+3,095
New +$197K ﹤0.01% 673
2017
Q2
Sell
-7,356
Closed -$446K 580
2017
Q1
$446K Buy
+7,356
New +$446K 0.01% 497
2015
Q3
Sell
-5,829
Closed -$317K 591
2015
Q2
$317K Sell
5,829
-167
-3% -$9.37K 0.02% 438
2015
Q1
$329K Buy
+5,996
New +$340K 0.02% 415
2014
Q4
Sell
-6,649
Closed -$376K 378
2014
Q3
$376K Buy
6,649
+2,503
+60% +$141K 0.04% 213
2014
Q2
$229K Sell
4,146
-14
-0.3% -$764 0.04% 295
2014
Q1
$225K Buy
+4,160
New +$215K 0.05% 237

Other funds holding MRK

Rafferty Asset Management's MRK Position: Q1 2026 in Review

Rafferty Asset Management reduced its Merck (MRK) stake by 28% in Q1 2026, selling an estimated $8.84M and leaving 193,053 shares worth $23.2M. The position accounts for 0.09% of the portfolio, ranked #115.

Rafferty Asset Management first reported a position in MRK in Q1 2014 and has held it in 36 quarters since. The position peaked at $35M in Q1 2024. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Rafferty Asset Management held 193,053 shares of Merck worth $23.2M as of Q1 2026.
  • Rafferty Asset Management sold 76,567 Merck shares in Q1 2026, an estimated $8.84M.
  • Merck made up 0.09% of Rafferty Asset Management's portfolio in Q1 2026, its #115 holding.
  • Rafferty Asset Management first reported a position in Merck in Q1 2014 and has held it in 36 quarters since.
  • Rafferty Asset Management's Merck position peaked at $35M in Q1 2024.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Rafferty Asset Management's 13F filing for Q1 2026, filed 15 May 2026.